Concepedia

Publication | Closed Access

Bevacizumab and irinotecan for recurrent oligodendroglial tumors

71

Citations

27

References

2009

Year

Abstract

This regimen is effective in recurrent oligodendrogliomas, and the overall tolerance is acceptable.

References

YearCitations

Page 1